Ligand Pharmaceuticals Inc (Symbol: LGND), which makes up 0.29% of the SPDR S&P 400 Mid Cap Growth ETF (Symbol: MDYG), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $4,737,194 worth of LGND, making it the #140 largest holding. The table below details the recent insider buying activity observed at LGND:
LGND — last trade: $123.85 — Recent Insider Buys:
|03/13/2019||John L. Higgins||Chief Executive Officer||2,500||$114.29||$285,725|
And Brinks Co (Symbol: BCO), the #163 largest holding among components of the SPDR S&P 400 Mid Cap Growth ETF (Symbol: MDYG), shows 2 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $4,172,157 worth of BCO, which represents approximately 0.25% of the ETF's total assets at last check. The recent insider buying activity observed at BCO is detailed in the table below:
BCO — last trade: $85.56 — Recent Insider Buys:
|03/13/2019||Jason Aryeh||Director||202||$112.51||$22,727||03/08/2019||Ronald James Domanico||EVP, Chief Financial Officer||3,000||$72.39||$217,170|
|03/13/2019||John L. Higgins||Chief Executive Officer||2,500||$114.29||$285,725||03/11/2019||Douglas A. Pertz||President and CEO||10,000||$72.92||$729,250|
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.